Colorectal cancer, encompassing both colon and rectal cancers, is a significant health concern worldwide. In 2022, there were over 1.9 million new cases globally, making it the third most common cancer. (wcrf.org)
Colorectal cancer begins in the colon or rectum, parts of the large intestine. It often starts as small growths called polyps, which can develop into cancer over time. Early detection through regular screenings is crucial, as it can lead to more effective treatment outcomes. (mayoclinic.org)
In the United States, approximately 151,000 adults are diagnosed with colorectal cancer annually, including over 106,000 new cases of colon cancer and about 45,000 new cases of rectal cancer. The survival rate varies based on the cancer’s stage at diagnosis. For localized colon cancer, the five-year survival rate is around 90%, highlighting the importance of early detection and treatment. (cancer.org)
While some risk factors are beyond control, such as age and family history, lifestyle choices play a significant role in colorectal cancer risk. Factors that may increase risk include:
Surgical intervention is often the primary treatment for colorectal cancer, aiming to remove the tumor and surrounding tissue. Advancements in surgical techniques have improved recovery times and outcomes. However, some patients may face challenges during recovery, including the potential need for an ostomy—a surgical procedure that creates an opening in the abdomen to divert waste.
At Averto Medical, we are dedicated to enhancing your recovery experience. Our innovative ColoSeal ICD Device is designed to support healing after colorectal surgery, aiming to reduce the need for an ostomy and minimize complications. This device helps preserve the integrity of the bowel, supports healing, and minimizes patient burden.
For more information about the ColoSeal ICD Device and how it can assist in your recovery journey, please contact us.
